2023-04-01 2024-03-31 false Capium Accounts Production 1.1 06789286 bus:AbridgedAccounts 2023-04-01 2024-03-31 06789286 bus:FRS102 2023-04-01 2024-03-31 06789286 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 06789286 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 06789286 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 06789286 2023-04-01 2024-03-31 06789286 2024-03-31 06789286 bus:RegisteredOffice 2023-04-01 2024-03-31 06789286 core:WithinOneYear 2024-03-31 06789286 core:AfterOneYear 2024-03-31 06789286 bus:Director1 2023-04-01 2024-03-31 06789286 bus:Director1 2024-03-31 06789286 bus:Director1 2022-04-01 2023-03-31 06789286 bus:Director2 2023-04-01 2024-03-31 06789286 bus:Director2 2024-03-31 06789286 bus:Director2 2022-04-01 2023-03-31 06789286 2022-04-01 06789286 bus:LeadAgentIfApplicable 2023-04-01 2024-03-31 06789286 2022-04-01 2023-03-31 06789286 2023-03-31 06789286 core:WithinOneYear 2023-03-31 06789286 core:AfterOneYear 2023-03-31 06789286 bus:EntityAccountantsOrAuditors 2022-04-01 2023-03-31 06789286 core:PlantMachinery 2023-04-01 2024-03-31 06789286 core:PlantMachinery 2024-03-31 06789286 core:PlantMachinery 2023-03-31 06789286 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 06789286 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-03-31 06789286 core:NetGoodwill 2023-04-01 2024-03-31 06789286 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 06789286 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 06789286 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-03-31 06789286 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 06789286 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 06789286 core:Non-currentFinancialInstruments 2024-03-31 06789286 core:Non-currentFinancialInstruments 2023-03-31 06789286 core:ShareCapital 2024-03-31 06789286 core:ShareCapital 2023-03-31 06789286 core:RetainedEarningsAccumulatedLosses 2024-03-31 06789286 core:RetainedEarningsAccumulatedLosses 2023-03-31 06789286 dpl:Item1 2023-04-01 06789286 dpl:Item1 2024-03-31 06789286 dpl:Item1 2022-04-01 06789286 dpl:Item1 2023-03-31 iso4217:GBP xbrli:shares xbrli:pure
Logo On Report
Registered Number: 06789286
England and Wales

 

 

 

BALAJI HEALTH LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 April 2023

End date: 31 March 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 2,314    2,893 
2,314    2,893 
Current assets      
Cash at bank and in hand 69,844    49,045 
Creditors: amount falling due within one year (51,887)   (38,237)
Net current assets 17,957    10,808 
 
Total assets less current liabilities 20,271    13,701 
Net assets 20,271    13,701 
 

Capital and reserves
     
Called up share capital 100    100 
Profit and loss account 20,171    13,601 
Shareholders' funds 20,271    13,701 
 


For the year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 18 November 2024 and were signed on its behalf by:


-------------------------------
Dr Ajay Krishen Bhatnagar
Director
1
General Information
BALAJI HEALTH LIMITED is a private company, limited by shares, registered in England and Wales, registration number 06789286, registration address 1364 London Road, Norbury, Lonon, SW16 4DE.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Group accounts
The company is a parent company subject to the small companies regime. The company and its subsidiary comprise a small group. The company has, therefore, taken advantage of the option provided by section 398 of the Companies Act 2006 not to prepare group accounts.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Government grants
Government grants received are credited to deferred income. Grants towards capital expenditure are released to the income statement over the expected useful life of the assets. Grants received towards revenue expenditure are released to the income statement as the related expenditure is incurred.
Operating lease rentals
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
Research and development expenditure
Research and development expenditure is charged to the income statement in the period in which it is incurred.
Website cost
Planning and operating costs for the company's website are charged to the income statement as incurred.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Preference dividends
Where preference shares are classed as liabilities rather than equity any preference dividends paid are included in interest payable and similar charges within the income statement.
Goodwill
Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of years.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 20% Reducing Balance
2.

Average number of employees

Average number of employees during the year was 2 (2023 : 2).
3.

Tangible fixed assets

Cost or valuation Plant and Machinery   Total
  £   £
At 01 April 2023 13,563    13,563 
Additions  
Disposals  
At 31 March 2024 13,563    13,563 
Depreciation
At 01 April 2023 10,670    10,670 
Charge for year 579    579 
On disposals  
At 31 March 2024 11,249    11,249 
Net book values
Closing balance as at 31 March 2024 2,314    2,314 
Opening balance as at 01 April 2023 2,893    2,893 


2